Live
- Accused in stone pelting case arrested
- Hyderabad: Eatala, Raghunandan, DK Aruna file nomination papers
- Chandrababu to hold Praja Galam election campaign in Kurnool today
- Rajasthan CM casts his vote, says BJP will repeat history
- Ex-MP CM Kamal Nath, son Nakul Nath cast votes in Chhindwara
- Hyderabad: HC directs police to permit Hanuman Vijaya Yatra rally with 100 bikes on April 23
- LS polls: PM Modi to campaign in UP, MP and Maharashtra today
- ‘Narmada Pushkara Kshetra Darsini’ book released
- Gold rates in Delhi slashes, check the rates on 19 April 2024
- Gold rates in Visakhapatnam slashes, check the rates on 19 April 2024
Dr Reddy's acquires Habitrol Brand from Novartis
Highlights
Dr Reddy\'s Acquires Habitrol Brand From Novartis. Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc.
Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc. following issuance of the proposed consent order from the U.S. Federal Trade Commission (FTC) on November 26, 2014. The company had earlier entered into an asset purchase agreement with Novartis Consumer Health Inc. to acquire the title and rights of Habitrol® brand and to market the product in the U.S. market.
.jpg)
With this closure, the company has assumed responsibility for the product and will commence shipments of the product in the market shortly.
Next Story
ADVERTISEMENT
